H. Peter Vollmers

2.5k total citations
63 papers, 2.1k citations indexed

About

H. Peter Vollmers is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, H. Peter Vollmers has authored 63 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 34 papers in Immunology and 33 papers in Molecular Biology. Recurrent topics in H. Peter Vollmers's work include Monoclonal and Polyclonal Antibodies Research (39 papers), Glycosylation and Glycoproteins Research (23 papers) and Immunotherapy and Immune Responses (11 papers). H. Peter Vollmers is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (39 papers), Glycosylation and Glycoproteins Research (23 papers) and Immunotherapy and Immune Responses (11 papers). H. Peter Vollmers collaborates with scholars based in Germany, Australia and India. H. Peter Vollmers's co-authors include Stephanie Brändlein, Walter Birchmeier, Frank Hensel, H. K. Müller-Hermelink, Hans–Konrad Müller–Hermelink, Simon L. Goodman, Hans Konrad Müller‐Hermelink, J Dämmrich, Beat A. Imhof and Karl‐Heinz Heider and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

H. Peter Vollmers

63 papers receiving 2.0k citations

Peers

H. Peter Vollmers

IMMUN

RNMI

ONCOL

W J van Venrooij Netherlands

Claudia Curcio Italy

Mark Renz United States

S Hakomori United States

Kaihong Su United States

Christophe Blanchetot Netherlands

David F. Carmichael United States

Abby Maizel United States

Stephanie Brändlein Germany

Joseph Trotter United States

W J van Venrooij Netherlands

H. Peter Vollmers

1.2k ×1.1

747 ×0.8

IMMUN

889 ×1.2

RNMI

186 ×0.5

ONCOL

123 ×0.4

Citations per year, relative to H. Peter Vollmers H. Peter Vollmers (= 1×) peers W J van Venrooij

Countries citing papers authored by H. Peter Vollmers

Since Specialization

Citations

This map shows the geographic impact of H. Peter Vollmers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Peter Vollmers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Peter Vollmers more than expected).

Fields of papers citing papers by H. Peter Vollmers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Peter Vollmers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Peter Vollmers. The network helps show where H. Peter Vollmers may publish in the future.

Co-authorship network of co-authors of H. Peter Vollmers

This figure shows the co-authorship network connecting the top 25 collaborators of H. Peter Vollmers. A scholar is included among the top collaborators of H. Peter Vollmers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Peter Vollmers. H. Peter Vollmers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tchoudakova, Anna, Frank Hensel, Frank J. Schoenen, et al.. (2009). High level expression of functional human IgMs in human PER.C6® cells. mAbs. 1(2). 163–171. 44 indexed citations

Brändlein, Stephanie, et al.. (2008). A new tumor-specific variant of GRP78 as target for antibody-based therapy. Laboratory Investigation. 88(4). 375–386. 107 indexed citations

Vollmers, H. Peter & Stephanie Brändlein. (2007). Tumors: Too sweet to remember?. Molecular Cancer. 6(1). 78–78. 11 indexed citations

Vollmers, H. Peter & Stephanie Brändlein. (2007). Natural antibodies and cancer. Journal of Autoimmunity. 29(4). 295–302. 73 indexed citations

Vollmers, H. Peter & Stephanie Brändlein. (2006). Natural IgM antibodies: The orphaned molecules in immune surveillance. Advanced Drug Delivery Reviews. 58(5-6). 755–765. 53 indexed citations

Vollmers, H. Peter & Stephanie Brändlein. (2005). Death by stress: Antibody induced apoptosis. Methods and Findings in Experimental and Clinical Pharmacology. 27(3). 185–185. 22 indexed citations

Timmermann, W., Bertram Illert, H. Rückle-Lanz, et al.. (2004). Prognostic effect of CD55^SC-1 in gastric carcinoma (GC) and survival after treatment with the monoclonal antibody SC-1. Journal of Clinical Oncology. 22(14_suppl). 4067–4067. 5 indexed citations

Brändlein, Stephanie, Ines Beyer, Matthias Eck, et al.. (2003). Cysteine-rich fibroblast growth factor receptor 1, a new marker for precancerous epithelial lesions defined by the human monoclonal antibody PAM-1.. PubMed. 63(9). 2052–61. 22 indexed citations

Vollmers, H. Peter & Stephanie Brändlein. (2003). Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies. Human Antibodies. 11(4). 131–142. 22 indexed citations

10.

Hensel, Frank, R. Schulte Hermann, Stephanie Brändlein, et al.. (2001). Regulation of the New Coexpressed CD55 (Decay-Accelerating Factor) Receptor on Stomach Carcinoma Cells Involved in Antibody SC-1–Induced Apoptosis. Laboratory Investigation. 81(11). 1553–1563. 35 indexed citations

11.

Hensel, Frank, Stephanie Brändlein, Matthias Eck, et al.. (2001). A Novel Proliferation-Associated Variant of CFR-1 Defined by a Human Monoclonal Antibody. Laboratory Investigation. 81(8). 1097–1108. 23 indexed citations

12.

Hermann, R. Schulte, Frank Hensel, Eva‐Christina Müller, et al.. (2001). Deactivation of regulatory proteins hnRNP A1 and A2 during SC-1 induced apoptosis1. Human Antibodies. 10(2). 83–90. 26 indexed citations

13.

Hensel, Frank, et al.. (1999). Mitogenic autoantibodies inHelicobacter pylori-associated stomach cancerogenesis. International Journal of Cancer. 81(2). 229–235. 19 indexed citations

14.

Krenn, Veit, J Schedel, Frank Gohlke, et al.. (1997). Endothelial cells are the major source of sICAM-1 in rheumatoid synovial tissue. Rheumatology International. 17(1). 17–27. 15 indexed citations

15.

Krenn, Veit, H. Peter Vollmers, Philipp von Landenberg, et al.. (1996). Immortalized B-lymphocytes from rheumatoid synovial tissue show specificity for bacterial HSP 60. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 427(5). 511–518. 15 indexed citations

16.

Vollmers, H. Peter, et al.. (1995). Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody. Cancer. 76(4). 550–558. 28 indexed citations

17.

Vollmers, H. Peter, et al.. (1993). Cytogenetic differences between intestinal and diffuse types of human gastric carcinoma. Virchows Archiv B Cell Pathology Including Molecular Pathology. 64(1). 145–150. 19 indexed citations

18.

Vollmers, H. Peter, et al.. (1993). Characterization of four new gastric cancer cell lines. Virchows Archiv B Cell Pathology Including Molecular Pathology. 63(1). 335–343. 28 indexed citations

19.

Faller, Gerhard, et al.. (1990). HAB-1, a new heteromyeloma for continuous production of human monoclonal antibodies. British Journal of Cancer. 62(4). 595–598. 14 indexed citations

20.

Vollmers, H. Peter, Beat A. Imhof, Susanne Braun, et al.. (1984). Monoclonal antibodies which prevent experimental lung metastases. FEBS Letters. 172(1). 17–20. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact